×
News Home

Here's Why Midatech Pharma Ads (MTP) Rose on Monday

Monday, April 05, 2021 04:55 PM | Kyle Depontes
Here's Why Midatech Pharma Ads (MTP) Rose on Monday

Midatech Pharma (MTP) stock rose on Monday after the the European Patent Register approved one of Midatech's previous patent applications for an experimental therapy. Shares of Midatech (MTP) finished up 2% at market close to finish at $2.32 a share, but had reached as high as $2.62 a share earlier in the afternoon.

Why Did Midatech Pharma (MTP) Rise Today?

Midatech shares finished higher on Monday after the European Patent Register granted one of Midatech's applications for a nano-particle based liver-targeting therapy. The patent means EU regulators found the treatment to be unlike existing patents and grants the company some protection from competition for that product.

Historically, MTP has focused on the development of pharmaceutical products in the field of nanomedicine and sustained release technology.

Sentiment Score - ,bullish

Midatech Pharma PLC-ADR has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MTP!

Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas. The company has only one operating segment Pipeline Research and Development. The research and development activities involve the discovery and development of pharmaceutical products in the field of nanomedicine and sustained release technology.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App